[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Somatostatin.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Somatostatin.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Somatostatin.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Somatostatin.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Somatostatin.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Somatostatin is combined with Thiopental.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Somatostatin.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Somatostatin.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Somatostatin.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Somatostatin.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Somatostatin.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Somatostatin.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Somatostatin.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Somatostatin.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Somatostatin.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Somatostatin.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Somatostatin.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Somatostatin.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be decreased when combined with Somatostatin.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Somatostatin.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Somatostatin.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Somatostatin.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Somatostatin.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Somatostatin.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Somatostatin.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Barbital.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Somatostatin.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Somatostatin.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Somatostatin.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Somatostatin.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin detemir.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Somatostatin.]
[L01EC02, dabrafenib, The metabolism of Dabrafenib can be decreased when combined with Somatostatin.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Somatostatin.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Somatostatin.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Somatostatin.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Somatostatin.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Somatostatin.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Somatostatin.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Somatostatin.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Somatostatin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Somatostatin.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Somatostatin.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Somatostatin.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Somatostatin.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Somatostatin.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin degludec.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Somatostatin.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Somatostatin.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Somatostatin.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Somatostatin.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Somatostatin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Somatostatin.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Somatostatin.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Somatostatin.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Somatostatin.]
[N04BC01, bromocriptine, The serum concentration of Bromocriptine can be increased when it is combined with Somatostatin.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Somatostatin.]
[V10XX04, lutetium Lu 177 dotatate, The therapeutic efficacy of Lutetium Lu 177 dotatate can be decreased when used in combination with Somatostatin.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Somatostatin.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Somatostatin.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Somatostatin.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Somatostatin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Somatostatin.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Somatostatin.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Somatostatin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Somatostatin.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Somatostatin.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Somatostatin.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Somatostatin.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Somatostatin.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Somatostatin.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Somatostatin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Somatostatin.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Somatostatin.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Somatostatin.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Somatostatin.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Somatostatin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Somatostatin.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Somatostatin.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Somatostatin.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Somatostatin.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Somatostatin.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Somatostatin.]
[V09IX09, edotreotide gallium ga-68, Somatostatin may decrease effectiveness of Edotreotide gallium Ga-68 as a diagnostic agent.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin pork.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Somatostatin.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Somatostatin.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Somatostatin.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Somatostatin.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Somatostatin.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Somatostatin.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Somatostatin.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Somatostatin.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Somatostatin.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Somatostatin.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin human.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Somatostatin.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Somatostatin.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Somatostatin.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Somatostatin.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Somatostatin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin glargine.]
[H01AX01, pegvisomant, The risk or severity of increased transaminases can be increased when Somatostatin is combined with Pegvisomant.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Somatostatin.]
[S01XA18, cyclosporine, The bioavailability of Cyclosporine can be decreased when combined with Somatostatin.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Somatostatin.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Somatostatin.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Somatostatin.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Somatostatin.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Somatostatin.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Somatostatin.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Somatostatin.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Somatostatin.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be decreased when combined with Somatostatin.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Somatostatin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Somatostatin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Somatostatin.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Somatostatin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Somatostatin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Somatostatin.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Somatostatin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Somatostatin.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Somatostatin.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Somatostatin.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Somatostatin.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Somatostatin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Somatostatin.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be decreased when combined with Somatostatin.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Somatostatin.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Somatostatin.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Somatostatin.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Somatostatin is combined with Barbexaclone.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Somatostatin.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Somatostatin.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Somatostatin.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Somatostatin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Somatostatin.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Somatostatin.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Somatostatin.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Somatostatin.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Hexobarbital.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Somatostatin.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Somatostatin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Somatostatin.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Somatostatin.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Somatostatin.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Somatostatin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Somatostatin.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Somatostatin.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Somatostatin.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Methylphenobarbital.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Methohexital.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Somatostatin.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Somatostatin.]
[N02CA04, methysergide, The metabolism of Methysergide can be decreased when combined with Somatostatin.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Somatostatin.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Somatostatin.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Somatostatin.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Amobarbital.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Somatostatin.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Somatostatin.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Somatostatin.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Somatostatin.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Somatostatin.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Pentobarbital.]
[N03AA02, phenobarbital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Somatostatin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Somatostatin.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Somatostatin.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Somatostatin.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Somatostatin is combined with Insulin lispro.]
[N03AA03, primidone, The risk or severity of adverse effects can be increased when Somatostatin is combined with Primidone.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Somatostatin.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Somatostatin.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Somatostatin.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Somatostatin.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Somatostatin is combined with Secobarbital.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Somatostatin.]
